Press Releases

Featured Press Releases

BIO Statement on Passage of Bipartisan…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and…

Learn more

BIO Appoints Joe Franklin, JD, PhD, as Chief…

Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and…

Learn more

Biotechnology Innovation Organization (BIO)…

WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…

Learn more

BIO World Congress Announces 2017 GreenTech Investor Sessions

June 8, 2017

BIO today announced that eleven emerging companies will make formal presentations to investors during GreenTech Investor Sessions at the 2017 BIO World Congress on Industrial Biotechnology.

Convention to Feature Modern Ag Innovation Programming

June 6, 2017

Washington, D.C. (June 6, 2017) – Today, BIO announced programming and speakers for its Modern Ag Innovation Day, which will take place on Tuesday, June 20th at BIO’s 2017 International Convention (June 19-22 in San Diego). Programming will feature…

GM Crops Increase Environmental Sustainability and Farmer Incomes

June 5, 2017

Washington, D.C. (June 5, 2017) – Over the last twenty years, biotech crops have increased agriculture’s environmental sustainability, while providing significant economic benefits, according to a newly released global impacts study.

BIO Statement on Supreme Court Ruling in Impression Products v. Lexmark International

May 30, 2017

Washington, DC (May 30, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to the Supreme Court’s ruling in Impression Products v. Lexmark International.

POET Founder, Chairman and CEO Jeff Broin to Receive 2017 BIO George Washington Carver Award

May 25, 2017

BIO today announced that POET Founder, Chairman and CEO Jeff Broin will receive the 10th annual George Washington Carver Award for Innovation in Industrial Biotechnology. The award will be presented on Monday July 24, 2017, during a morning plenary…

BIO Applauds Creation of FDA Opioid Policy Steering Committee

May 24, 2017

Washington, DC (May 24, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug…

Astellas Expands Advocacy Engagement with Focused Outreach

May 23, 2017

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives of patients. Sponsoring events such as the BIO Patient and Health Advocacy Summit to be held on November 3-4 is a way the Astellas…

BIO Statement on President’s Proposed 2018 Budget

May 23, 2017

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2018 budget proposal.

Biotech Industry Continues Strong Growth in 2016; San Diego Setting Pace for State, Nation

May 17, 2017

Mayor Faulconer, Industry Leaders Reveal Latest Data, Including Major Economic Benefits of June BIO 2017 Convention

BIO Joins Diverse Coalition Promoting Market-Based Solutions to Address Prescription Drug Costs, Increase Patient Access and Choice

May 17, 2017

Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition, free-market-oriented solutions to lower healthcare costs while…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.